| Type : |
Journal |
| Internet-link : |
http://www.ijpc.com/Abstracts/Abstract.cfm?ABS=2464 |
|
| Forskerhold : |
Houston - M.D.Anderson Cancer Center |
| Forfattere : |
Trissel LA, Zhang Y, Koontz SE. |
| Titel : |
Temozolomide Stability in Extemporaneously Compounded Oral Suspensions |
| Nummer : |
Int J Pharm Compound ; 10, 5: 396-399. 2006 |
|
| Cotationvaleur : |
|
| Fysisk stabilitet : |
|
| Kemisk stabilitet : |
|
| Andre metoder : |
|
| Kommentarer : |
|
Lister
 Temozolomide
|
 |
 |
 |
Povidone K30 |
 |
 |
 |
 |
 |
300 mg
Temodar® |
| Povidone K30 |
150 mg |
| Citronsyre vandfri |
7.5 mg |
| Renset vand |
0.45 ml |
| OraPlus® |
15 ml |
| Orasweet® |
>> 30 ml |
|
4°C |
 |
| 60 |
 |
|
|
|
|
|
300 mg
Temodar® |
| Povidone K30 |
150 mg |
| Citronsyre vandfri |
7.5 mg |
| Renset vand |
0.45 ml |
| OraPlus® |
15 ml |
| Orasweet SF ® |
>> 30 ml |
|
4°C |
|
| 60 |
|
|
|
|
|
